Aubagio

Sanofi Q4 earnings hit by weak dollar, generic competition
Reuters
Thu, 02/1/24 - 11:25 am
Sanofi
earnings
Dupixent
Aubagio
Novartis sues FDA over its stance on Sanofi blockbuster’s exclusivity
Endpoints
Tue, 03/9/21 - 10:49 am
Novartis
generics
Sandoz
FDA
Aubagio
multiple sclerosis
MS
To challenge Ocrevus, German Merck takes on Aubagio
EP Vantage
Sun, 02/23/20 - 02:00 pm
Ocrevus
Merck KGaA
Aubagio
evobrutinib
MS
multiple sclerosis
Janssen’s MS pill outshines Sanofi’s Aubagio in phase 3 trial
Pharmaforum
Thu, 09/12/19 - 10:28 am
JNJ
Janssen
ponesimod
Sanofi
Aubagio
relapsing multiple sclerosis
Novartis’ ofatumumab meets primary endpoints in two phase 3 RMS trials
Pharmaceutical Business Review
Mon, 09/2/19 - 12:24 pm
Novartis
ofatumumab
OMB157
Aubagio
clinical trials
relapsing multiple sclerosis
Janssen’s Ponesimod Finds Success in Head-to-Head Multiple Sclerosis Trial
BioSpace
Fri, 07/26/19 - 10:59 am
Janssen
JNJ
ponesimod
Sanofi
Aubagio
relapsing multiple sclerosis
How Aubagio became the most switched-to oral MS drug
Medical Marketing and Media
Tue, 10/31/17 - 10:02 am
Aubagio
MS
multiple sclerosis
Sanofi
Sanofi to be a leader in MS, but not yet
BioPharma Dive
Wed, 03/22/17 - 10:35 pm
Sanofi
MS
multiple sclerosis
Lemtrada
Aubagio
If copies of Teva's Copaxone hit, oral MS rivals could be the real threat
Fierce Pharma
Wed, 02/15/17 - 09:41 am
Teva Pharmaceutical
Copaxone
MS
multiple sclerosis
generics
Tecfidera
Biogen
Gilenya
Novartis
Aubagio
Sanofi
Payers keep squeezing MS drugmakers--and they may just take their tactics elsewhere
Fierce Pharma
Wed, 06/22/16 - 07:08 pm
MS
multiple sclerosis
payers
Sanofi
Aubagio
Teva Pharmaceutical
Copaxone
Biogen
Tecfidera
Avonex
Sanofi Chipping Away At Biogen's MS Dominance
Investors.com
Mon, 11/30/15 - 06:45 pm
Sanofi
Biogen
MS
multiple sclerosis
Aubagio
Tecfidera
Sanofi calls out Genzyme, multiple sclerosis drug, as main drivers of growth again
Bizjournals.com
Thu, 07/30/15 - 10:33 am
Sanofi
Genzyme
MS
multiple sclerosis
Aubagio
earnings
Saskatchewan to fund treatment with AUBAGIO® for Relapsing Remitting Multiple Sclerosis
Yahoo/CNW Group
Sat, 11/1/14 - 12:52 pm
Aubagio
multiple sclerosis
MS
Sanofi
Sanofi aims to grow Genzyme unit with new drugs and acquisitions
Yahoo/Reuters
Thu, 09/11/14 - 08:48 am
Sanofi
Genzyme
Aubagio
Lemtrada
Bring out the confetti: 7 of 2013's launches will join Sovaldi, Tecfidera in blockbuster land
Fierce Pharma Marketing
Thu, 06/26/14 - 10:21 am
drug launches
Tecfidera
Sovaldi
Aubagio
Imbruvica
Tivicay
Breo Ellipta and Anoro Ellipta
Kadcyla
Invokana
Pomolyst
Analysis of FDA side-effect reports flags Sanofi, Celgene meds
Fierce Pharma
Tue, 01/28/14 - 11:37 am
Celegene
FDA
Sanofi
side effects
Pomalyst
Tecfidera
Biogen Idec
Aubagio
Sanofi’s Aubagio Wins Final Approval From U.K. Cost Agency NICE
Bloomberg
Wed, 01/22/14 - 08:34 am
Sanofi
Aubagio
NICE
MS
multiple sclerosis
Sanofi wins EU approval for second MS treatment
Reuters
Tue, 09/17/13 - 09:46 am
Sanofi
Europe
MS
multiple sclerosis
Aubagio
Lemtrada
European Commission Approves Genzyme’s Once-Daily, Oral Multiple Sclerosis Treatment Aubagio (teriflunomide)
Yahoo/BusinessWire
Sat, 08/31/13 - 11:13 am
Genzyme
multiple sclerosis
Aubagio
MS
Biogen investors encouraged by ruling on rival drug, shares jump
Marketwatch
Fri, 06/28/13 - 12:19 pm
Biogen Idec
Sanofi
Aubagio
Tecfidera
MS
multiple sclerosis

Pages